SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales is pegged at Rs. 649.11 millions for the September 2021 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 723.15 millions during the year-ago period.A big decline of -36.23% was reported for the quarter ended September 2021 to Rs. 128.40  millions from Rs. 201.34 millions of corresponding previous quarter.Operating profit for the quarter ended September 2021 decreased to 195.43 millions as compared to 303.78 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 649.11 723.15 -10.24 1376.63 1337.20 2.95 2834.73 2473.54 14.60
Other Income 19.02 17.36 9.56 28.45 24.65 15.42 68.23 90.01 -24.20
PBIDT 195.43 303.78 -35.67 469.05 542.73 -13.58 1074.44 857.67 25.27
Interest 0.08 0.17 -52.94 0.16 0.60 -73.33 0.84 11.00 -92.36
PBDT 195.35 303.61 -35.66 468.89 542.13 -13.51 1073.60 846.67 26.80
Depreciation 22.91 21.55 6.31 45.59 42.73 6.69 89.32 88.14 1.34
PBT 172.44 282.06 -38.86 423.30 499.40 -15.24 984.28 758.53 29.76
TAX 44.04 80.72 -45.44 109.42 144.85 -24.46 274.16 178.98 53.18
Deferred Tax -0.76 -0.36 111.11 -0.52 2.68 -119.40 25.72 -14.91 -272.50
PAT 128.40 201.34 -36.23 313.88 354.55 -11.47 710.12 579.55 22.53
Equity 223.56 223.36 0.09 223.56 223.36 0.09 223.46 223.36 0.04
PBIDTM(%) 30.11 42.01 -28.33 34.07 40.59 -16.05 37.90 34.67 9.31

Advanced Enzyme Share Price

299.70 1.10 (0.37%)
22-Apr-2026 12:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1663.20
Dr. Reddys Lab 1225.70
Cipla 1236.25
Zydus Lifesciences 928.85
Lupin 2314.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×